Why are advanced technologies increasingly important for complex small molecule synthesis?
In this whitepaper we outline what the growth in technology platforms used in chemical synthesis means for small, medium and large pharma companies. Selecting a CMO partner is increasingly determined by the size, strength and flexibility of their advanced technology portfolio. This whitepaper will help you assess what you need for large or complex API projects – especially those focusing on large-scale manufacture of HPAPIs.
In this whitepaper we outline what the growth in technology platforms used in chemical synthesis means for small, medium and large pharma companies. Selecting a CMO partner is increasingly determined by the size, strength and flexibility of their advanced technology portfolio. This whitepaper will help you assess what you need for large or complex API projects – especially those focusing on large-scale manufacture of HPAPIs.